Literature DB >> 8862408

Sin Nombre virus mRNA synthesis.

K L Hutchinson1, C J Peters, S T Nichol.   

Abstract

Sin Nombre (SN) virus is the major etiologic agent of hantavirus pulmonary syndrome, a severe respiratory disease with high mortality. Like other hantaviruses, SN virus causes an inapparent chronic infection of the natural rodent reservoir and tends to grow slowly and produce little cytopathic effect even in highly susceptible Vero E6 tissue culture cells. An electrochemiluminescent quantitative PCR approach was developed to allow examination of SN virus RNA transcription in synchronously infected cells. Although virion particles contain equimolar ratios of the three negative-strand genome RNA segments (S, M, and L), rates and levels of accumulation of the corresponding N, GPC, and L viral mRNAs varied. The smallest mRNA (N) was detectable earliest and plateaued at the highest level, where as the largest mRNA (L) appeared latest and at the lowest plateau level. In addition, all three mRNAs were found to share a common 5' capped primer initiation mechanism, but appeared to have different mRNA termination mechanisms. The N mRNA 3' terminus mapped to position 1435 on the S segment, in close proximity to a CCC-rich suspected transcription termination motif. The GPC mRNA 3' terminus contained a poly(A) tall and mapped to a U8 transcription termination-polyadenylation motif reminiscent of those seen in other negative-strand RNA viruses. Finally, the L mRNA 3' terminus appeared identical to the L segment antigenome 3' terminus.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8862408     DOI: 10.1006/viro.1996.0515

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  22 in total

1.  Accumulation of terminally deleted RNAs may play a role in Seoul virus persistence.

Authors:  B J Meyer; C Schmaljohn
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

2.  Hantavirus nucleocapsid protein oligomerization.

Authors:  A Alfadhli; Z Love; B Arvidson; J Seeds; J Willey; E Barklis
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

3.  Trimeric hantavirus nucleocapsid protein binds specifically to the viral RNA panhandle.

Authors:  M A Mir; A T Panganiban
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

4.  Signatures of host mRNA 5' terminus for efficient hantavirus cap snatching.

Authors:  Erdong Cheng; Mohammad A Mir
Journal:  J Virol       Date:  2012-07-11       Impact factor: 5.103

5.  The hantavirus nucleocapsid protein recognizes specific features of the viral RNA panhandle and is altered in conformation upon RNA binding.

Authors:  M A Mir; A T Panganiban
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

6.  A shared transcription termination signal on negative and ambisense RNA genome segments of Rift Valley fever, sandfly fever Sicilian, and Toscana viruses.

Authors:  César G Albariño; Brian H Bird; Stuart T Nichol
Journal:  J Virol       Date:  2007-02-28       Impact factor: 5.103

7.  Analysis of hantavirus genetic diversity in Argentina: S segment-derived phylogeny.

Authors:  Marlene C Bohlman; Sergey P Morzunov; John Meissner; Mary Beth Taylor; Kimiko Ishibashi; Joan Rowe; Silvana Levis; Delia Enria; Stephen C St Jeor
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

8.  Molecular biology of rift valley Fever virus.

Authors:  Michele Bouloy; Friedemann Weber
Journal:  Open Virol J       Date:  2010-04-22

9.  Rift Valley fever virus(Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention.

Authors:  Michel Pepin; Michele Bouloy; Brian H Bird; Alan Kemp; Janusz Paweska
Journal:  Vet Res       Date:  2010 Nov-Dec       Impact factor: 3.683

10.  Elevated generation of reactive oxygen/nitrogen species in hantavirus cardiopulmonary syndrome.

Authors:  Ian C Davis; Allan J Zajac; Kurt B Nolte; Jason Botten; Brian Hjelle; Sadis Matalon
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.